Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2123

Actual shortage: 50 (2%)
Anticipated shortage: 9 (0%)
Avoided shortage: 19 (1%)
Resolved: 2045 (96%)

Discontinuation Reports

101

To be discontinued: 1 (1%)
Discontinued: 98 (97%)
Reversed: 2 (2%)

Late reports

444 (20%)

Overdue reports

38 (63%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SUPEUDOL 20 20MG TABLET Resolved 2021-02-08 2021-03-09 133537
SUPEUDOL 20 20MG TABLET Resolved 2023-11-13 2023-11-21 210069
SUPEUDOL 10 10MG SUPPOSITORY Resolved 2022-09-01 2023-12-14 168433
SUPEUDOL 10 10MG TABLET Actual shortage 2024-09-23 2025-05-12 238341
SUPEUDOL 20 20MG TABLET Actual shortage 2025-02-18 2025-02-18 250522
SUPEUDOL 5 5MG TABLET Resolved 2021-03-15 2021-03-30 135633
SUPEUDOL 5 5MG TABLET Actual shortage 2024-09-23 2025-05-12 238345
TIMOLOL MALEATE-EX 0.25% SOLUTION (EXTENDED RELEASE) Actual shortage 2024-05-13 2025-05-12 227853
TIMOLOL MALEATE-EX 0.5% SOLUTION (EXTENDED RELEASE) Actual shortage 2024-08-12 2025-05-12 235074
TIMOLOL MALEATE-EX 0.5% SOLUTION (EXTENDED RELEASE) Resolved 2023-12-19 2024-05-08 213825
TIMOLOL MALEATE-EX 0.25% SOLUTION (EXTENDED RELEASE) Resolved 2019-09-25 2021-09-14 94633
TIMOLOL MALEATE-EX 0.50% SOLUTION (EXTENDED RELEASE) Resolved 2019-12-10 2021-10-04 100873
TIMOLOL MALEATE-EX 0.25% SOLUTION (EXTENDED RELEASE) Resolved 2023-03-13 2023-05-16 186993
TIMOLOL MALEATE-EX 0.25% SOLUTION (EXTENDED RELEASE) Resolved 2022-06-22 2022-11-17 163223
TOBRAMYCIN INHALATION SOLUTION 300MG SOLUTION Resolved 2018-02-05 2018-07-03 38757
TOBRAMYCIN INHALATION SOLUTION 300MG SOLUTION Resolved 2020-11-27 2020-12-14 129111
TOBRAMYCIN INHALATION SOLUTION 300MG SOLUTION Resolved 2021-01-12 2021-01-18 131408
TOBRAMYCIN INHALATION SOLUTION 300MG SOLUTION Avoided shortage 2021-09-02 2021-09-14 145010
TOBRAMYCIN INHALATION SOLUTION 300MG SOLUTION Resolved 2017-03-14 2017-05-17 2553
TOBRAMYCIN INJECTION USP 10MG SOLUTION Resolved 2022-10-26 2023-01-27 172692

Showing 2041 to 2060 of 2123

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Discontinued 2020-06-22 2020-06-22 118553

Showing 1 to 20 of 101